Clinical trial

Study of Histrelin Subdermal Implant in Patients With Prostate Cancer

NCT01394263

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Histrelin hydrogel implant Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Zoladex goserelin implant Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of Histrelin Subdermal Implant in Patients With Prostate Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2000-05-01

PhasePHASE3

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Adenocarcinoma of the Prostateverified · MONDO: prostate adenocarcinoma

Interventions

Histrelin hydrogel implantDRUG

Zoladex goserelin implantDRUG

Sponsors & collaborators

Endo USA Inc., a Keenova Therapeutics Companylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01394263 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.